{"schema_version":"secwatch.filing_event.v1","accession":"0000886744-25-000048","form_type":"8-K","ticker":"GERN","cik":"0000886744","company_name":"GERON CORP","filed_at":"2025-08-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:46.592190+00:00","generated_at":"2026-05-17T20:16:48.544437+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.72,"calibrated_materiality_score":0.72,"confidence":"high","headline":"Geron Q2 net product revenue $49.0M, net loss narrows to $16.4M; new CEO named","bullets":["Net product revenue of $49.0M from RYTELO in Q2 2025, up 24% QoQ; demand up 17% QoQ with over 1,000 ordering accounts.","Net loss of $16.4M ($0.02/share) vs $67.4M loss ($0.10) in Q2 2024, driven by rising RYTELO sales and lower R&D costs.","Phase 3 IMpactMF trial in myelofibrosis now over 95% enrolled; full enrollment expected by year-end 2025.","Harout Semerjian appointed President and CEO; seasoned commercial hematology and oncology leader.","FY2025 operating expense guidance maintained at $270M-285M; cash and securities $432.6M as of June 30."],"urls":{"canonical":"https://secwatch.observer/filing/0000886744-25-000048","json":"https://secwatch.observer/filing/0000886744-25-000048.json","markdown":"https://secwatch.observer/filing/0000886744-25-000048.md","text":"https://secwatch.observer/filing/0000886744-25-000048.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/886744/000088674425000048/0000886744-25-000048-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/886744/000088674425000048/gern-20250806.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T20:16:48.544437+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}